6 Best PET-CT Centers in Haryana

Thorough cancer staging with PET-CT in Haryana requires AERB-licensed facilities equipped with modern scanners and specialty tracers. Gurgaon, Faridabad, and Rohtak host the state's primary nuclear medicine clusters.

Key Takeaways

• AERB licensing verification is the mandatory first step before booking any PET-CT scan in Haryana
• Digital TOF scanners detect smaller lesions compared to conventional PET-CT systems
• Specialty tracers (PSMA, DOTA) are required for prostate and neuroendocrine cancers
• Integrated cancer hospitals reduce turnaround time by co-locating nuclear medicine with oncology teams
• CGHS coverage for PET-CT applies only at empaneled centers and confirmed malignancies

Why AERB Licensing Matters for Pet-Ct Cancer Staging

Where can you get thorough cancer staging with PET-CT in Haryana? The main clusters are Gurgaon, Faridabad, and Rohtak — but before booking, verify that the facility holds current AERB licensing. This government registry is your verification baseline; unlicensed centers cannot legally operate PET-CT scanners in India.

What AERB Licensing Guarantees

AERB — the Atomic Energy Regulatory Board — enforces radiation safety standards for all nuclear medicine facilities. A licensed PET-CT center meets strict requirements: radiation shielding adequate for the higher-energy radionuclides used in molecular imaging, controlled radioactive waste disposal, staff training in radiation safety protocols, and regular quality-control audits. Because cyclotron-produced radionuclides have higher energy than other diagnostic isotopes, these precautions are non-negotiable. Facilities must submit detailed layout plans showing room dimensions and occupancy patterns, arrange spaces from low-activity to high-activity zones, and maintain equipment calibration logs. The AERB certification process ensures that every scan meets national safety thresholds — protecting both patients and staff from unnecessary radiation exposure.

Verifying AERB Status Before Booking

Don't rely on marketing claims alone. Many patients choose a PET-CT center based on website promises or referral networks, only to discover later that the facility lacks proper licensing. Follow these three steps:

1. Visit the AERB registry PDF at aerb.gov.in, this is the authoritative list of licensed PET-CT centers, updated regularly by the government.
2. Search for the facility name by location, the registry is organized by state, so scan the Haryana section and confirm the hospital name appears.
3. Confirm the license issue date is current, expired or pending renewals mean the facility cannot legally perform PET-CT scans until reinstatement.

A facility without AERB approval operates outside India's nuclear medicine regulatory framework, your scan results may lack the quality assurance and safety oversight that licensed centers provide. When staging decisions hinge on accurate imaging, verification takes two minutes and eliminates risk.

Once you understand why AERB licensing is non-negotiable, the next step is identifying which facilities in Haryana currently hold active licenses.

Licensed Pet-Ct Centers in Haryana: AERB Registry Overview

The Atomic Energy Regulatory Board (AERB) maintains the authoritative registry of facilities licensed to operate PET-CT scanners in India. In Haryana, AERB has licensed a cluster of centers concentrated in Gurgaon, with additional facilities in Faridabad and Rohtak. Facilities not appearing in the AERB registry cannot legally operate PET-CT equipment, regardless of marketing claims.

Gurgaon Pet-Ct Facilities

Gurgaon hosts three AERB-licensed PET-CT centers as of May 2026. The concentration of licensed facilities in Gurgaon reflects the city's position as a medical hub within the National Capital Region.

Fortis Hospotel Limited appears in the AERB registry as a licensed facility in Gurgaon. The center operates as part of the Fortis Memorial Research Institute network.

Andromeda Cancer Hospital holds AERB certification for its PET-CT facility in Sonipat, serving the broader Gurgaon-Delhi corridor. The hospital operates an AERB-certified PET-CT facility equipped with the GE Discovery IQ 2 system. Detailed information about the nuclear medicine department is available on the hospital's nuclear medicine page.

Medanta Hospital is listed in the AERB registry under its Noida entity (Medanta Hospital, Noida - A Unit of Global Health Limited), serving patients from both Noida and the Gurgaon region.

Faridabad and Rohtak Options

House of Diagnostics Healthcare Pvt Ltd operates two AERB-licensed PET-CT facilities in Haryana, one in Faridabad and another in New Delhi. The Faridabad center provides an alternative for patients in southeastern Haryana.

Metro Specialty Hospitals Pvt Ltd is listed as a licensed facility in Faridabad, adding capacity in the region adjacent to Delhi.

National Cancer Institute, Jhajjar serves the Rohtak district and is listed in the AERB registry. As a government-affiliated institution, it provides access to PET-CT for patients in western Haryana.

The AERB registry is updated periodically; verify current licensing status before scheduling a scan at any facility.

AERB licensing confirms regulatory compliance, but clinical capability depends on scanner generation and tracer inventory.

Comparing Pet-Ct Facilities: Scanner Technology and Tracer Availability

Scanner generation and tracer inventory define the clinical reach of a PET-CT center. Digital time-of-flight (TOF) systems deliver higher resolution and faster scan times than conventional scanners, improving detection of small lesions critical for accurate staging. Specialty tracers, PSMA for prostate cancer, DOTA for neuroendocrine tumors, Choline for recurrence imaging, extend diagnostic coverage beyond standard FDG glucose-metabolism scans. Yet public data on tracer availability remains sparse, requiring patients to confirm inventory directly with each center before booking.

Digital TOF Pet-Ct Vs Older Scanner Generations

Digital TOF scanners reconstruct images with superior lesion-detection sensitivity compared to conventional systems, a difference that matters most when staging early-stage or small-volume disease. Facilities offering digital TOF technology report faster acquisition times and lower radiation exposure, though most Haryana centers do not disclose scanner generation in public marketing. Andromeda Cancer Hospital operates an AERB-certified facility equipped with the GE Discovery IQ 2, a digital TOF system. Patients evaluating scanner technology should request written confirmation of model name and AERB licensing status before finalizing their choice.

FDG Vs Specialty Tracer Availability

FDG remains the workhorse tracer for whole-body cancer staging, but prostate and neuroendocrine malignancies demand specialty radiotracers for accurate imaging. Andromeda's tracer portfolio includes standard FDG-PET alongside advanced options for prostate, neuroendocrine, and other malignancies, though public data on specific tracer availability beyond FDG is not disclosed on the hospital website, requiring direct inquiry for prostate or neuroendocrine cancer patients. Sarvodaya Cancer Institute lists PSMA, DOTA, and Choline tracers on its public treatment pages, simplifying pre-booking confirmation. Medanta and Fortis publish similar tracer inventories. Amerix Super Speciality Hospital and Dr. Pooja Gupta Onco do not disclose tracer availability publicly; patients must call to verify PSMA or DOTA stock before scheduling. PET-CT scan fees typically range from ₹18,000 to ₹35,000 depending on tracer type and facility location.

Scanner technology and tracer availability determine diagnostic accuracy, but turnaround time and oncology coordination affect treatment planning speed.

Turnaround Time and Integrated Oncology Support

When cancer staging demands speed, report turnaround and oncology coordination become decision factors. Centers with in-house nuclear medicine teams typically deliver PET-CT reports within 24 to 48 hours, while facilities outsourcing imaging workflows may add 1 to 3 days for external radiologist review and report finalization. This delay cascades into treatment planning: every additional day defers the tumor board meeting, pushes back surgical scheduling, and extends the patient's diagnostic limbo.

In-House Vs Outsourced Imaging Workflows

In-house nuclear medicine departments eliminate handoff delays. Yashoda Hospital's PET CT Department, managed by expert lab technicians and doctors committed to quality healthcare, exemplifies the state-of-the-art in-house model. Andromeda Cancer Hospital follows a similar structure: Dr. Aashish Gambhir, Director of Nuclear Medicine, PET CT and Nuclear Theranostics, leads on-site PET-CT operations with same-day or next-day report turnaround. In contrast, standalone imaging centers without specialist staff must batch scans, transmit DICOM files to external interpreters, and wait for radiologist availability. The Mayo Clinic notes that PET scans often find changes earlier than CT or MRI, making rapid interpretation critical. Outsourced workflows sacrifice that advantage when reports arrive days after the scan.

On-Site Oncology Teams for Treatment Coordination

Integrated oncology centers co-locate surgical, medical, and radiation oncology with nuclear medicine and pathology. Andromeda Cancer Hospital coordinates PET-CT plus IHC testing turnaround within one week for tumor board review, enabling Wednesday tumor boards to plan multimodality therapy without external referral delays. Standalone imaging facilities lack this integration: patients receive reports but must independently schedule consults with surgeons, medical oncologists, and radiation oncologists at separate institutions. Each handoff adds administrative lag and coordination friction. When staging accuracy depends on correlating PET-CT findings with histopathology, genomic markers, and clinical context, as the Mayo Clinic's overview implies, having all specialists under one roof compresses decision cycles from weeks to days. That time margin often determines whether neoadjuvant chemotherapy starts before tumor progression or surgery proceeds under optimal staging confidence.

Turnaround times are typical and vary by facility workflow, confirm current turnaround with the center before booking.

After evaluating technology and turnaround, the final decision factor for most patients is cost and insurance coverage.

Insurance Coverage and Cost Considerations for Haryana Patients

Cost Range and What Drives Price Variation

PET-CT scan fees in Haryana typically range from ₹18,000 to ₹35,000. The final price you pay depends on three key factors: the radiotracer type, the clinical indication your oncologist prescribes, and the facility's location and equipment. An FDG-PET scan for lung cancer staging will cost significantly less than a specialty tracer like Ga-68 PSMA for prostate cancer or DOTA for neuroendocrine tumours. Facilities in urban centres, such as Sarvodaya Cancer Institute in Faridabad, often charge at the higher end of the spectrum due to advanced detector technology (BGO crystals, 3-ring systems, QClear algorithms) that improves lesion detection. Rural or suburban centres may offer lower headline prices but may not carry the full suite of specialty tracers your case requires.

CGHS Empanelment Verification for Government Employees

If you hold a CGHS card, verifying that a facility's oncology services are empanelled is a non-negotiable first step. Follow this four-step workflow before booking your scan:

1. Visit the official CGHS empanelment portal and navigate to the hospital search page.
2. Search for the facility by name and location (city, state), results display the hospital's empanelment category and expiry date.
3. Confirm that the facility's empanelment certificate explicitly includes oncology services, some hospitals are empanelled for general care only and do not cover cancer diagnostics or PET-CT scans.
4. Call the facility's billing department to verify current coverage limits and any exclusions, annual renewals mean published lists are often outdated, and real-time confirmation prevents billing surprises at discharge.

Andromeda Cancer Hospital provides clear CGHS empanelment guidance for government employees seeking PET-CT scans, and Mayom Hospital in Gurgaon uses multidisciplinary tumor board evaluations to ensure staging decisions align with insurance reimbursement criteria.

When Insurance Covers Pet-Ct and When It Doesn't

Insurance coverage for PET-CT varies by policy and cancer indication, most public and private insurers approve FDG-PET for confirmed malignancies (staging, restaging, treatment response assessment) but may deny coverage for screening or non-oncologic applications. Your insurer will require documentation showing that PET-CT is medically necessary for your case. For example, when a CT scan appears normal but your oncologist suspects residual disease, PET-CT's ability to detect metabolic activity becomes key, cancer cells absorb radioactive glucose more than normal cells, making PET scans particularly valuable for staging lymphoma, lung cancer, and other malignancies where anatomical imaging alone is insufficient. Before booking, confirm with your insurer that your specific clinical indication (e.g., post-chemotherapy restaging, suspected recurrence) falls within covered use cases, generic "cancer screening" requests are routinely rejected.

Conclusion

Standalone imaging centers suit patients who already have an oncology team managing their care; integrated cancer hospitals like Andromeda or Sarvodaya add value when coordinating surgery, chemotherapy, and radiation after staging. Digital TOF scanners deliver higher staging accuracy but may cost 10 to 15% more than conventional PET-CT, the investment is justified for small-lesion detection in early-stage cancers.

As specialty tracer availability expands in Haryana (PSMA for prostate, DOTA for neuroendocrine), patients will gain access to more precise staging without traveling to metro hubs, verify tracer inventory when booking to match your cancer type.

Verify AERB licensing for your chosen center, confirm CGHS empanelment if applicable, and schedule a consultation at Andromeda Cancer Hospital to discuss PET-CT staging options for your cancer type.

Frequently Asked Questions

Why is my doctor recommending a PET scan when my CT showed normal results?

PET-CT detects metabolic activity that anatomical imaging may miss, even when CT findings appear normal. In lymphoma and lung cancer staging, metabolic imaging identifies active disease before structural changes become visible. Most insurers approve FDG-PET for confirmed malignancies requiring staging or restaging assessments.

How do I verify if a PET-CT center in Haryana is AERB-licensed?

Visit the AERB registry PDF, search for the facility name by location (Gurgaon, Faridabad, Rohtak), and confirm the license issue date is current. The registry lists all legally authorized nuclear medicine facilities in India. Unlicensed centers cannot operate PET-CT scanners under Indian law.

What is the difference between FDG and specialty tracers for PET-CT?

FDG is the standard tracer for whole-body cancer staging across most malignancies. Specialty tracers, PSMA for prostate, DOTA for neuroendocrine, Choline for brain, deliver superior accuracy for specific cancer types. Tracer availability varies by center; confirm inventory directly before booking.

Does CGHS cover PET-CT scans for cancer staging in Haryana?

Yes, CGHS covers PET-CT for confirmed malignancies at empaneled centers. Check the CGHS portal for empanelment status, verify oncology-specific coverage limits, and confirm current status before booking. Coverage typically applies to staging, restaging, and treatment response assessment, not screening or non-oncologic indications.

How long does it take to get PET-CT results in Haryana?

In-house nuclear medicine departments typically deliver reports within 24-48 hours. Outsourced imaging adds one to three days. Integrated centers like Andromeda coordinate PET-CT and IHC testing within one week for tumor board review. Confirm current turnaround time directly with the facility before scheduling.

Why does PET-CT cost vary between ₹18,000 and ₹35,000 in Haryana?

Final cost depends on tracer type (FDG costs less than specialty tracers), clinical indication, and facility location. Specialty tracers for prostate or neuroendocrine cancers increase pricing. Scanner technology and institutional overheads also affect fees. Request itemized quotes before booking to understand cost components.

Can I get a PET-CT scan at a standalone imaging center or do I need a cancer hospital?

Both options exist in Haryana. Standalone centers like Amerix offer PET-CT but require external referrals for treatment planning. Integrated cancer hospitals (Andromeda, Sarvodaya) co-locate nuclear medicine with surgical, medical, and radiation oncology teams, reducing referral delays and coordinating tumor board reviews.

Sources

1. List of PET-CT Centres licensed by AERB (as on May 20, 2026) - www.aerb.gov.in (2026)
2. Regulatory requirements for designing PET-CT facility in India - pmc.ncbi.nlm.nih.gov
3. List of PET-CT centres licensed by AERB (as on February 28, 2026) - mgw3.aerb.gov.in (2026)
4. Digital PET CT Scan in Delhi NCR @ ₹9,999 | Molecular Diagnostics and Therapy - www.molecularit.com
5. PET Scan vs CT Scan – Which One Do I Need for Cancer? - www.pratikpatil.co.in